ReviewBMC medical ethics2019
A review and analysis of new Italian law 219/2017: 'provisions for informed consent and advance directives treatment'.
Review in BMC medical ethics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
36 citing papers in PubMed.
- The Real-Time Support Role of Augmented Reality Technology in Shared Decision-Making in Neurosurgery Under the SEGUE Framework: Randomized Controlled Trial.Journal of medical Internet research · 2026Trial
- Advance care planning in patients with advanced cancer: A 6-country, cluster-randomised clinical trial.PLoS medicine · 2020Trial
- Knowledge and perception of end-of-life bioethics among medical students. A comparative study between the University of Verona (Italy) and the University of Halle (Germany).BMC medical ethics · 2026Article
- Informed Consent in Patients with Aphasia: Scoping Review of Clinical Decision-Making Tools and Medico-Legal Issues.Brain sciences · 2026Review
- Brain donation rules in Italy and worldwide: overview of a cutting-edge topic for human brain research.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025Review
- Health Professionals' Views on Euthanasia: Impact of Traits, Religiosity, Death Perceptions, and Empathy.Healthcare (Basel, Switzerland) · 2025Article
- End of Life in Italy: Ethical and Legal Perspectives.Healthcare (Basel, Switzerland) · 2025Review
- A medico-legal approach to developing a structured decision-making process for patients refusing blood transfusions.Frontiers in public health · 2025Article
- Integration of resources in social and healthcare services for ensuring the continuity of care to frail individuals aged 65 or over: an Italian experience.Frontiers in public health · 2025Article
- The experience of Tunisian public healthcare system toward decentralization to the reduction of health inequalities in low-, middle- income countries.International journal for equity in health · 2024Article
- Shared care planning in people with cognitive disorders and dementia: a survey among patients and caregivers in Italy.BMC medical ethics · 2024Article
- Review
- Governance models for historical hospitals: evidence from Italy.BMC health services research · 2024Article
- The ethical foundations of patient-centered care in aesthetic medicine.Philosophy, ethics, and humanities in medicine : PEHM · 2024Review
- Article
- Case report: "Scared to deaf": medical-legal evaluation of a suspected post -traumatic stress disorder".Frontiers in psychiatry · 2024Article
- Philosophy leading the way: An interdisciplinary approach to study communication of severe diagnoses.PloS one · 2024Article
- The "Criminal Shield": Criminal Liability for Healthcare Professionals during the COVID-19 Pandemic.Healthcare (Basel, Switzerland) · 2023Article
- Art therapy in Alzheimer's disease. An opportunity of collaboration between intersectoral public and private organizations in the co-design of health and social care services.Frontiers in psychiatry · 2023Article
- Italian law n. 219/2017 on consent and advance directives: survey among Ethics Committees on their involvement and possible role.BMC medical ethics · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn December 2017, Law 219/2017, 'Provisions for informed consent and advance directives', was approved in Italy. The law is the culmination of a year-long process and the subject of heated debate throughout Italian society. Contentious issues (advance directives, the possibility to refuse medical treatment, the withdrawal of medical treatment, nutrition and hydration) are addressed in the law. MAIN TEXT: What emerges clearly are concepts such as quality of life, autonomy, and the right to accept or refuse any medical treatment - concepts that should be part of an optimal relationship between the patient and healthcare professionals. The law maximizes the value of the patient's time to decide. Every patient is allowed to make choices for the present (consenting to or refusing current treatment) as well as for the future, conceived as a continuation of the present, and to decide what comes next, based on what he/she already knows. The law identifies three distinct but converging paths towards the affirmation of a care relationship based on reciprocal trust and respect: the possibility to consent to or refuse treatment, the shared care planning, and advance directives.
conclusionsThe fundamental point to emerge from the new Italian law is that consensus is an essential connotation of the treatment relationship. Consensus is not limited to the acceptance/rejection of medical treatment but is ongoing. It is projected into the future through shared care planning and advance directives which act as tools for self-determination and the manifestation of the beliefs and preferences of persons unable to express their will. These principles are in line with the idea of appropriate care as evaluated from two different perspectives, one of scientific adequacy and the other commensurate with the individual's resources, fragility, values, and beliefs. Surely, however, the new law is not the end of the matter on issues such as conscientious objection, which is deeply rooted within the Italian cultural and political debate. In this regard, healthcare institutions and policymakers will be called upon to develop and implement organizational policies aimed at the management of foreseeable conscientious objection in this field.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.